Basilea Pharmaceutica Ag Allschwil
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of BSLN-SW would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2004) — listing | $28,464 0.8× | $41,308 0.8× |
| Year 6 (2009) | $25,280 1.0× | $36,780 1.0× |
| Year 11 (2014) | $18,160 1.0× | $26,465 1.0× |
| Year 16 (2019) | $13,252 1.2× | $19,354 1.2× |
| Year 21 (2024) | $4,218 1.2× | $6,237 1.2× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with BSLN
For illustration only — not investment advice. Past performance is not indicative of future results.